Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
18 hedge funds and large institutions have $4.12M invested in Orgenesis Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
13% more funds holding
Funds holding: 16 → 18 (+2)
9% more capital invested
Capital invested by funds: $3.77M → $4.12M (+$344K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.03M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$59.2K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$10.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.04K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
Venator Capital Management
Toronto,
Ontario, Canada
|
-$677K |
| 2 |
BlackRock
New York
|
-$8.44K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$4.91K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2K |
| 5 |
SFG
SevenBridge Financial Group
Harrisburg,
Pennsylvania
|
-$1K |
ORGS Hedge Fund Activity: Q3 2019 in Review
18 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q3 2019, worth a combined $4.12M — up 9.1% from $3.77M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ORGS positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.03M. The largest seller was Venator Capital Management, cutting an estimated $677K.
- 18 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q3 2019, up from 16 in Q2 2019.
- Funds reported $4.12M of Orgenesis Inc. Common Stock stock for Q3 2019, up 9.1% quarter-over-quarter.
- 5 funds opened new Orgenesis Inc. Common Stock positions in Q3 2019 and 2 closed out, a net change of +3 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q3 2019 was Vanguard Group, an estimated $1.03M added.
- The largest Orgenesis Inc. Common Stock seller in Q3 2019 was Venator Capital Management, an estimated $677K sold.
Based on aggregated 13F filings for Q3 2019.